Prognosis and predictive factors in prostate cancer

被引:5
作者
Albiges-Sauvin, L. [1 ]
Levy, A. [1 ]
Massard, C. [1 ]
Fizazi, K. [1 ]
机构
[1] Inst Gustave Roussy, F-94800 Villejuif, France
关键词
prostate cancer; prognosis factors; predictive factor; angiogenesis; circulating tumor cell; DIGITAL RECTAL EXAMINATION; SEMINAL-VESICLE INVASION; BEAM RADIATION-THERAPY; RADICAL PROSTATECTOMY; GENE-EXPRESSION; PRETREATMENT NOMOGRAM; EXTERNAL VALIDATION; EXTRACAPSULAR EXTENSION; POSTOPERATIVE NOMOGRAM; BIOCHEMICAL RECURRENCE;
D O I
10.1684/bdc.2009.0846
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate carcinoma represents a major public health issue and an important share of the oncological practice. As well as for other types of carcinoma, the therapeutic strategy might be guided by the identification of prognosis factors. For a localized prostate cancer, 3 pretherapeutic factors are often used: evaluation of the clinical stage, Gleason's score on prostatic biopsies and prostate specific antigen (PSA). Their combination is at the origine of multiple prognosis classifications and allowed the elaboration of statistical models, such as nomograms. These different tools are suitable for pretherapeutic evaluations of the histologic stage as well as for the evaluation of recurrence's risk. In case of metastastic disease, other clinical and biological prognosis factors state for the tumor's activity. Currently the identification of biomolecular markers through the techniques of tissue micro-array, the analysis of biological markers of angiogenesis as well as the analysis of circulating tumor cells could contribute to a better definition of the prognosis and predictive factors of this pathology.
引用
收藏
页码:439 / 449
页数:11
相关论文
共 59 条
  • [1] A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: A TAX327 study analysis
    Armstrong, Andrew J.
    Garrett-Mayer, Elizabeth S.
    Yang, Yi-Chun Ou
    de Wit, Ronald
    Tannock, Ian F.
    Eisenberger, Mario
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6396 - 6403
  • [2] Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer
    Armstrong, Andrew J.
    Garrett-Mayer, Elizabeth
    Yang, Yi-Chun Ou
    Carducci, Michael A.
    Tannock, Ian
    de Wit, Ronald
    Eisenberger, Mario
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3965 - 3970
  • [3] EXTERNAL VALIDATION OF THE UPDATED PARTIN TABLES IN A COHORT OF FRENCH AND ITALIAN MEN
    Bhojani, Naeem
    Salomon, Laurent
    Capitanio, Umberto
    Suardi, Nazareno
    Shariat, Shahrokh F.
    Jeldres, Claudio
    Zini, Laurent
    Pharand, Daniel
    Peloquin, Francois
    Arjane, Philippe
    Abbou, Claude C.
    De La Taille, Alexandre
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 347 - 352
  • [4] Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
    Brasso, K
    Christensen, IJ
    Johansen, JS
    Teisner, B
    Garnero, P
    Price, PA
    Iversen, P
    [J]. PROSTATE, 2006, 66 (05) : 503 - 513
  • [5] Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer
    Briganti, Alberto
    Chun, Felix K. -H.
    Salonia, Andrea
    Gallina, Andrea
    Farina, Elena
    Da Pozzo, Luigi F.
    Rigatti, Patrizio
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. BJU INTERNATIONAL, 2006, 98 (04) : 788 - 793
  • [6] Development and external validation of an extended 10-core biopsy nomogram
    Chun, Felix K. -H.
    Briganti, Alberto
    Graefen, Markus
    Montorsi, Francesco
    Porter, Christopher
    Scattoni, Vincenzo
    Gallina, Andrea
    Walz, Jochen
    Haese, Alexander
    Steuber, Thomas
    Erbersdobler, Andreas
    Schlomm, Thorsten
    Ahyai, Sascha A.
    Currlin, Eike
    Valiquette, Luc
    Heinzer, Hans
    Rigatti, Patrizio
    Huland, Hartwig
    Karakiewicz, Pierre I.
    [J]. EUROPEAN UROLOGY, 2007, 52 (02) : 436 - 445
  • [7] Development and external validation of an extended repeat biopsy nomogram
    Chun, Felix K. -H.
    Briganti, Alberto
    Graefen, Markus
    Porter, Christopher
    Montorsi, Francesco
    Haese, Alexander
    Scattoni, Vincenzo
    Borden, Lester
    Steuber, Thomas
    Salonia, Andrea
    Schlomm, Thorsten
    Latchemsetty, Kalyan
    Walz, Jochen
    Kim, Jason
    Eichelberg, Christian
    Currlin, Eike
    Ahyai, Sascha A.
    Erbersdobler, Andreas
    Valiquette, Luc
    Heinzer, Hans
    Rigatti, Patrizio
    Huland, Hartwig
    Karakiewicz, Pierre I.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (02) : 510 - 515
  • [8] COLEMAN RE, 2008, BR J CANC IN PRESS, V98, P1836
  • [9] Clinical features of metastatic bone disease and risk of skeletal morbidity
    Coleman, Robert E.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6243S - 6249S
  • [10] Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer
    Cooper, Colin S.
    Campbell, Colin
    Jhavar, Sameer
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (12): : 677 - 687